HAEMATO AG Xetra

Equities

HAE

DE000A289VU3

Pharmaceuticals

End-of-day quote Xetra 06:00:00 2024-02-04 pm EST 5-day change 1st Jan Change
26.2 EUR -0.76% Intraday chart for HAEMATO AG -1.50% -5.76%
This article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Chart HAEMATO AG
More charts
Haemato AG, previously Windsor AG, is a Germany-based pharmaceutical company. The Company trades and patent-free and patent-protected medicines and generic drugs with focus on oncology, human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS), neurology, rheumatology, urology, cardiovascular diseases and other chronic diseases. The Company's main markets are Europe, North America and Japan. It also imports medicines from within the European Economic Area in form of parallel imports and re-imports. The Company's subsidiaries are Haemato Pharm GmbH, Heamato Med GmbH, Castell Pharma BV, Sanate GmbH and Heamato Asia Co Ltd. Customers can order medicine through phone, fax and e-mail, among others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
22.2 EUR
Average target price
33 EUR
Spread / Average Target
+48.65%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock
  2. Equities
  3. Stock HAEMATO AG
  4. Stock HAEMATO AG - Xetra
  5. News HAEMATO AG
  6. Haemato to Delist from Frankfurt Bourse's Open Market
+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019
Replicate our performance
fermer